I agree, to read Ira Shoulson being so pleased at these recent findings reassures me he will fight heaven and earth to have it realesed from the PCH and made available to the HD community ASAP ( whether through phase 3 trials or accelerated approval).
It would be nice to hear from someone in the HD community what their thoughts are on these findings and what it means to them.
Verbatim patient-reported outcomes and trails making test B (TMT-B) performance in the REACH2HD tria, page-3
Add ATH (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.3¢ |
Change
0.000(0.00%) |
Mkt cap ! $15.96M | |||
| Open | High | Low | Value | Volume |
| 0.3¢ | 0.3¢ | 0.3¢ | $4.579K | 1.526M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 749591 | 0.3¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.4¢ | 133062022 | 26 |
View Market Depth
| Last trade - 14.03pm 13/09/2024 (20 minute delay) ? |
| ATH (ASX) Chart |